
Jennifer Doan
Examiner (ID: 2317, Phone: (571)272-2346 , Office: P/2883 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2883, 2874 |
| Total Applications | 1999 |
| Issued Applications | 1770 |
| Pending Applications | 114 |
| Abandoned Applications | 149 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6830391
[patent_doc_number] => 20030181449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Methods and compositions for the treatment of pain'
[patent_app_type] => new
[patent_app_number] => 10/168761
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18938
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20030181449.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168761 | Methods and compositions for the treatment of pain | Feb 23, 2003 | Abandoned |
Array
(
[id] => 6797571
[patent_doc_number] => 20030176445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Substituted 1,4-dihydropyridine compounds as bradykinin antagonists'
[patent_app_type] => new
[patent_app_number] => 10/366486
[patent_app_country] => US
[patent_app_date] => 2003-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28582
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176445.pdf
[firstpage_image] =>[orig_patent_app_number] => 10366486
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/366486 | Substituted 1,4-dihydropyridine compounds as bradykinin antagonists | Feb 12, 2003 | Abandoned |
Array
(
[id] => 6797566
[patent_doc_number] => 20030176440
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Aralkyl substituted piperazine compounds'
[patent_app_type] => new
[patent_app_number] => 10/365344
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10103
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176440.pdf
[firstpage_image] =>[orig_patent_app_number] => 10365344
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/365344 | Aralkyl substituted piperazine compounds | Feb 10, 2003 | Issued |
Array
(
[id] => 6918752
[patent_doc_number] => 20050096313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Piperidine derivatives and their use as antagonists of tachykinins'
[patent_app_type] => utility
[patent_app_number] => 10/502261
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17354
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096313.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502261
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502261 | Piperidine derivatives and their use as antagonists of tachykinins | Feb 4, 2003 | Issued |
Array
(
[id] => 6847498
[patent_doc_number] => 20030166665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => '4-,5-,6-And 7-indole derivatives useful for the treatment of CNS disorders'
[patent_app_type] => new
[patent_app_number] => 10/359052
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5789
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166665.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359052
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359052 | 4-,5-,6-and 7-indole derivatives useful for the treatment of CNS disorders | Feb 3, 2003 | Issued |
Array
(
[id] => 6991459
[patent_doc_number] => 20050090496
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Sulphonyl compounds with 5-ht6 receptor affinity'
[patent_app_type] => utility
[patent_app_number] => 10/503682
[patent_app_country] => US
[patent_app_date] => 2003-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3207
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20050090496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503682 | Sulphonyl compounds with 5-ht6 receptor affinity | Feb 3, 2003 | Abandoned |
Array
(
[id] => 6835245
[patent_doc_number] => 20030162791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Phenylpiperazines'
[patent_app_type] => new
[patent_app_number] => 10/343232
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1652
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162791.pdf
[firstpage_image] =>[orig_patent_app_number] => 10343232
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/343232 | Phenylpiperazines | Jan 29, 2003 | Issued |
Array
(
[id] => 928569
[patent_doc_number] => 07314879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-01
[patent_title] => 'Melanocortin receptor agonists'
[patent_app_type] => utility
[patent_app_number] => 10/500476
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31150
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/314/07314879.pdf
[firstpage_image] =>[orig_patent_app_number] => 10500476
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/500476 | Melanocortin receptor agonists | Jan 20, 2003 | Issued |
Array
(
[id] => 6852302
[patent_doc_number] => 20030144505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Novel compounds'
[patent_app_type] => new
[patent_app_number] => 10/345499
[patent_app_country] => US
[patent_app_date] => 2003-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3253
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10345499
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/345499 | Novel compounds | Jan 15, 2003 | Abandoned |
Array
(
[id] => 6766357
[patent_doc_number] => 20030100757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => '2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor'
[patent_app_type] => new
[patent_app_number] => 10/340699
[patent_app_country] => US
[patent_app_date] => 2003-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9255
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100757.pdf
[firstpage_image] =>[orig_patent_app_number] => 10340699
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/340699 | 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives interacting with the dopamine D4 receptor | Jan 9, 2003 | Abandoned |
Array
(
[id] => 359772
[patent_doc_number] => 07485651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-03
[patent_title] => 'Compounds with activity on muscarinic receptors'
[patent_app_type] => utility
[patent_app_number] => 10/338937
[patent_app_country] => US
[patent_app_date] => 2003-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 14052
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/485/07485651.pdf
[firstpage_image] =>[orig_patent_app_number] => 10338937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/338937 | Compounds with activity on muscarinic receptors | Jan 6, 2003 | Issued |
Array
(
[id] => 7281332
[patent_doc_number] => 20040063709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => '3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/335789
[patent_app_country] => US
[patent_app_date] => 2003-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21673
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063709.pdf
[firstpage_image] =>[orig_patent_app_number] => 10335789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/335789 | 3,4-di-substituted pyridazinediones as CXC chemokine receptor antagonists | Jan 1, 2003 | Issued |
Array
(
[id] => 1073805
[patent_doc_number] => 06838470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Arylpiperidinopropanol and arylpiprazinopropanol derivatives and pharmaceuticals containing the same'
[patent_app_type] => utility
[patent_app_number] => 10/331508
[patent_app_country] => US
[patent_app_date] => 2002-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21072
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838470.pdf
[firstpage_image] =>[orig_patent_app_number] => 10331508
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/331508 | Arylpiperidinopropanol and arylpiprazinopropanol derivatives and pharmaceuticals containing the same | Dec 30, 2002 | Issued |
Array
(
[id] => 6684206
[patent_doc_number] => 20030120070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Serotonin 5-HT1A and dopamin D2 receptor ligands'
[patent_app_type] => new
[patent_app_number] => 10/334481
[patent_app_country] => US
[patent_app_date] => 2002-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9804
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120070.pdf
[firstpage_image] =>[orig_patent_app_number] => 10334481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/334481 | Serotonin 5-HT1A and dopamin D2 receptor ligands | Dec 29, 2002 | Abandoned |
Array
(
[id] => 6740831
[patent_doc_number] => 20030158200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Pyridazinyl phenyl hydrazones useful against congestive heart failure'
[patent_app_type] => new
[patent_app_number] => 10/221348
[patent_app_country] => US
[patent_app_date] => 2002-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9762
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158200.pdf
[firstpage_image] =>[orig_patent_app_number] => 10221348
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/221348 | Pyridazinyl phenyl hydrazones useful against congestive heart failure | Dec 25, 2002 | Issued |
Array
(
[id] => 6740834
[patent_doc_number] => 20030158203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Triazolo-pyridazine derivatives as ligands for GABA receptors'
[patent_app_type] => new
[patent_app_number] => 10/324968
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7693
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158203.pdf
[firstpage_image] =>[orig_patent_app_number] => 10324968
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/324968 | Triazolo-pyridazine derivatives as ligands for GABA receptors | Dec 19, 2002 | Abandoned |
Array
(
[id] => 5814968
[patent_doc_number] => 20060084657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Piperazine derivative'
[patent_app_type] => utility
[patent_app_number] => 10/499011
[patent_app_country] => US
[patent_app_date] => 2002-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15327
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084657.pdf
[firstpage_image] =>[orig_patent_app_number] => 10499011
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/499011 | Piperazine derivative | Dec 18, 2002 | Abandoned |
Array
(
[id] => 6805428
[patent_doc_number] => 20030232822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Indole derivatives useful for the treatment of CNS disorders'
[patent_app_type] => new
[patent_app_number] => 10/327670
[patent_app_country] => US
[patent_app_date] => 2002-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9086
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232822.pdf
[firstpage_image] =>[orig_patent_app_number] => 10327670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/327670 | Indole derivatives useful for the treatment of CNS disorders | Dec 16, 2002 | Abandoned |
Array
(
[id] => 7330775
[patent_doc_number] => 20040254374
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases'
[patent_app_type] => new
[patent_app_number] => 10/496019
[patent_app_country] => US
[patent_app_date] => 2004-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15366
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20040254374.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496019
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496019 | Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases | Dec 8, 2002 | Issued |
Array
(
[id] => 7122921
[patent_doc_number] => 20050014750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-20
[patent_title] => 'Isochroman compounds for treatment of cns disorders'
[patent_app_type] => utility
[patent_app_number] => 10/496535
[patent_app_country] => US
[patent_app_date] => 2002-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24141
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20050014750.pdf
[firstpage_image] =>[orig_patent_app_number] => 10496535
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/496535 | Isochroman compounds for treatment of CNS disorders | Dec 5, 2002 | Issued |